MELK inhibition effectively suppresses growth of glioblastoma and cancer stem-like cells by blocking AKT and FOXM1 pathways
Authors:
Preprint
- 7 May 2020
- preprint
- Published by Springer Nature in Research Square
Abstract
Background: Glioblastoma multiforme (GBM) is a devastating disease yet no effective drug treatment has been established to date. Glioblastoma stem-like cells (GSCs) are insensitive to treatment and may be one of the reasons for the relapse of GBM. Maternal embryonic leucine zipper kinase gene (MELK) plays an important role in the malignant proliferation and the maintenance of GSC stemness properties of GBM. However, the therapeutic effect of targeted inhibition of MELK on GBM remains unclear. Methods: This study analyzed the effect of a MELK oral inhibitor, OTSSP167, on GBM proliferation and the maintenance of GSC stemness. Results: OTSSP167 significantly inhibited cell proliferation, colony formation, invasion, and migration of GBM. OTSSP167 treatment reduced the expression of cell cycle G2/M phase-related proteins, Cyclin B1 and Cdc2, while up-regulation the expression of cell cycle inhibitor protein p21 and subsequently induced cell cycle arrest at the G2/M phase. OTSSP167 effectively prolonged the survival of tumor-bearing mice and inhibited tumor cell growth in an in vivo mouse model. It also reduced protein kinase B (Akt) phosphorylation by inhibiting MELK, thereby disrupting the proliferation and invasion of GBM cells. Furthermore, OTSSP167 inhibited the proliferation and neurosphere formation of GSCs by reducing forkhead box M1 (FOXM1) phosphorylation and transcriptional activity. Interestingly, the inhibitory effect of OTSSP167 on the proliferation of GSCs was 4-fold more effective than GBM cells. Conclusion: In conclusion, MELK inhibition suppresses the growth of GBM and GSCs by double-blocking AKT and FOXM1 signals. Targeted inhibition of MELK may thus be potentially used as a novel treatment for GBM.Keywords
All Related Versions
This publication has 35 references indexed in Scilit:
- Increased DKC1 expression in glioma and its significance in tumor cell proliferation, migration and invasionInvestigational New Drugs, 2019
- Relationship between expression of XRCC1 and tumor proliferation, migration, invasion, and angiogenesis in gliomaInvestigational New Drugs, 2018
- Receptor tyrosine kinase-Ras-PI 3 kinase-Akt signaling network in glioblastoma multiformeMedical Oncology, 2018
- m 6 A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation ProgramCancer Cell, 2017
- Tumor vasculature and glioma stem cells: Contributions to glioma progressionCancer Letters, 2016
- The crystal structure of MPK38 in complex with OTSSP167, an orally administrative MELK selective inhibitorBiochemical and Biophysical Research Communications, 2014
- Downregulation of PAK5 inhibits glioma cell migration and invasion potentially through the PAK5-Egr1-MMP2 signaling pathwayBrain Tumor Pathology, 2013
- MELK-Dependent FOXM1 Phosphorylation is Essential for Proliferation of Glioma Stem CellsStem Cells, 2013
- Tumor-Specific Activation of the C-JUN/MELK Pathway Regulates Glioma Stem Cell Growth in a p53-Dependent MannerStem Cells, 2013
- Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cellsJournal of Neuroscience Research, 2007